Project Shivom

Project Shivom

Created using Figma
SHIVOM是一个分散的区块链平台,人们可以对其进行基因组测序和存储,从而实现高度可扩展和完全整合的医疗保健垂直。
  • 市场
    价钱
    第24H卷
    24H(价格)
    24H(体积)
  • CoinBene
    OMX/ETH ] 1,Inf [%count%一年前
    $ 0.0004
    $ 0.0009
    -49.79%
    -99.97%
  • Uniswap (v3)
    OMX/ETH ] 1,Inf [%count%一年前
    $ 0.0002
    $ 44.73
    -
    -
  • Coinsuper
    OMX/BTC ] 1,Inf [%count%一年前
    $ 0.0002
    -
    -
    -
  • Idex
    OMX/ETH ] 1,Inf [%count%一年前
    $ 0.0001
    -
    -
    -
  • DDEX
    OMX/WETH ] 1,Inf [%count%一年前
    $ 0.0002
    $ 2.56
    -
    -
  • Bamboo Relay
    OMX/WETH ] 1,Inf [%count%一年前
    -
    -
    -
    -
  • TokenJar
    OMX/WETH ] 1,Inf [%count%一年前
    -
    -
    -
    -
  • KuCoin
    OMX/BTC ] 1,Inf [%count%一年前
    $ 0.0007
    $ 731.49
    -
    -
  • KuCoin
    OMX/ETH ] 1,Inf [%count%一年前
    $ 0.0007
    $ 1.121 K
    -
    -
  • Bilaxy
    OMX/ETH
    -
    -
    -
    -
  • DDEX
    OMX/ETH
    -
    -
    -
    -
Main sale
2018年5月3日
2018年5月6日
100% 完成
$35 000 000
100% 硬帽子 完成
硬帽子 35 000 000.00 USD
past
Pre-Sale
2018年4月16日
2018年4月27日
100% 完成
$32 000 000
91% 硬帽子 完成
硬帽子 35 000 000.00 USD
past
令牌详细信息
断续器
OMX
接受的货币
ETH, BTC, FIAT
公司详情
注册国家
Germany
额外细节
KYC
分类
平台, 健康, 软件, 大数据

关于 Project Shivom

我们设想一个基因组数据无处不在的未来,其所有人都可以安全地获得有关增强医疗保健的见解。 Shivom开创了组学生态系统,通过在快速增长的个性化医疗市场中提供首创的投资主张,实现这一愿景,并采用最先进的区块链技术。

我们还将建立一个最先进的非营利性药物发现和精准医学组织。 Shivom的研究人员将使用数据驱动的工具和技术,特别是支持人工智能的机器学习方法,这将为改善全球医疗保健系统和服务带来希望。

区块链技术是我们的首选技术合作伙伴,因为它能够解决信任问题,包括患者同意,数据所有权,数据完整性和身份验证。区块链还可以管理复杂的数据权利,并允许使用智能合约进行细粒度访问。

特征

通过SHIVOM,每个人都能够对他们的基因组进行测序和存储,我们的生态系统将为其他提供商提供开放的网络市场,以及基因组数据分析和个性化医疗,以添加他们的应用和服务。解决方案将为个人,非营利组织,政府和营利性实体创造共同价值。 

技术信息

以太坊ERC20标准令牌。

%name%Roadmap

  • Q1 2017

  • Сonceptualization healthcare ecosystem initiated
  • Q2-Q3 2017

  • Seed round
  • Q3-Q4 2017

  • Shivom Roadshow starts
  • Q1 2018

  • Private round raised from major crypto vc’s
  • 阅读更多
  • Q1-Q2 2018

  • Innovation Council
  • Q1-Q2 2018

  • Partnership with state of AP
  • Q2 2018

  • OmiX tokens distributed
  • Q2 2018

  • Project Gaia (Partnerships for sequencing pilots globally- starting with biggest cancer hospital in AP
  • Q2 2018

  • Beta version platform product launch
  • Q2-Q3 2018

  • Establishment of sequencing processes and protocols
  • Q3 2018

  • Blockchain protocols for multiple encryption
  • Q3 2018

  • Co-development of new SNP panels for rare/complex disease
  • Q3 2018

  • Web Marketplace open
  • Q3 2018

  • First Genomics Lab setup
  • Q3 2018

  • Shivom Foundation
  • Q3-Q4 2018

  • Worldwide rollout of Shivom Platform
  • Q4 2018

  • Formation Shivom research division
  • Q4 2018/Q1 2019

  • Multi-omics Integration
  • Q1 2019

  • AI Platform

Project Shivom 球队

验证 58%

注意。未经证实的成员实际上可能不是团队成员

Axel Schumacher
Co-Founder and CEO
验证
Gourish Singla
Co-Founder & COO
验证

6 ICO

$43 000 000

Sally Eaves
Co-Founder & CMO
未验证

5 ICO

$49 878 980

Henry Ines
CIO
未验证
Natalie Pankova
Chief Scientific Officer
未验证
Agam Kansal
VP Marketing
验证

2 ICO

$225 378 014

Pierre Maarek
Investment Lead
未验证
Charles Leslie
Investment Lead
验证
Kayleen Schreiber
Design Lead
验证
Azam Shaghaghi
Head of Public Relations
未验证
Ajit Singh Kular
HEAD - SEARCH & DIGITAL MARKETING
验证
Dr. Rashad Ibrahim
MIDDLE EAST HEAD
验证

Project Shivom 面试

Axel Schumacher
As a team member, сan you tell us about your role in the project? What do you think about idea? Thank you!)
CEO
Axel has over 20 years of R&D leadership experience in genomics, epigenetics, biomarker discovery, Bio-IT, and aging & longevity. He is the Author of the ‘Blockchain & Healthcare Strategy Guide’, the standard compendium for the healthcare industry. Axel translates scientific discoveries into practical applications to help understand, diagnose, and treat complex disorders, but also to promote cutting-edge technologies that could transform precision medicine and the way we age. Axel is a Faculty-Member of the Blockchain Research Institute in Toronto. He holds a PhD in Human Genetics from the University of Cologne.
Gourish Singla
As a team member, сan you tell us about your role in the ICO project? What do you think about idea?
I am the COO and Co-founder of Project Shivom.
I believe this project will revolutionize the healthcare spectrum.
Agam Kansal
As a team member, сan you tell us about your role in the project? What do you think about idea? Thank you!)
VP Marketing
Charles Leslie
As a team member, сan you tell us about your role in the ICO project? What do you think about idea?
I'm really excited to be part of a project that is destined to revolutionize healthcare.
Kayleen Schreiber
As a team member, сan you tell us about your role in the ICO project? What do you think about idea?
I design and edit content to communicate Shivom's vision and purpose.
Ajit Singh Kular
As a team member, сan you tell us about your role in the ICO project? What do you think about idea?
I am working as a Search and Digital Marketing Head at Project Shivom.
Dr. Rashad Ibrahim
As a team member, сan you tell us about your role in the ICO project? What do you think about idea?
SHIVOM is a game changer for next generation Health Technology.
An amazing Idea utilizing distributed Ledger Technology Patroned by a great Team.

Project Shivom 最新消息

$ 0.0002
Crypto Stats
Daily, %:
Weekly, %:
Monthly, %:
Market Info
Market Cap:
$ 174.537 K
Volume 24h:
Circ. Supply:
943.082 M OMX
Ticker:
OMX

%name%Reviews

Samson Owiti
Cryptotrader, Crypto investor, Blockchain business expert

SHIVOM is a decentralized block chain platform where people can get their genome sequenced and stored hence enabling the establishment of a highly scalable and fully integrated health care vertical.

PROS:

  • Security: The merging of block chain and genomics enables the users to securely store  their genome sequenced data within the ecosystem  via a state of art cryptography
  • Increased market: The platform creates an open market free from exploitation by individuals  which enables the other providers to add their applications and services alongside the genomic data analytics
  • Incentives: The  platform incentivizes the patients directly for donating data to the research studies and organizations
  • Lower costs: The platform enables the whole process of genome tests to be conducted at a subsidized rates hence promoting mass production
  • Transparency: The platform users have full control over the accessibility of their data  within the platform  secure fashion
  • Good team: The platform has  a good team full of experience  led by  the CEO, Akash Guarav who is a block chain expert a and helped in facilitation of first block chain company in India
  • Improved global health: The  platform  eliminates third party involvement in handling the genome data of the patients and selling them to health organizations without the consent of the patients  through information control by the users hence increasing profits

CONS:

  • The platform application mentioned is not clearly generated
  • The  OMIX token exchangeability with other crypto currencies is not captured by the platform

SUGGESTIONS:

  • The platform management team should generate a user friendly application for all the users across the world
  • The OMIX token should be made exchangeable with other crypto currencies and fiat for easy  profit generation
阅读更多
OhHeyMatty
61
阅读更多
ICO Drops

24-Apr: I have no plans to participate in Project Shivom.

阅读更多
bitcoinexchangeguide.com
News, reviews

Judging from the negative point I have raised, the project does not sound of investment quality. However, the overall concept of the platform is unique, and the venture could face a revisit if the inefficiencies get the adequate solutions.

In conclusion for this stage, there is not enough information regarding the Shivom project. There is little information on the part of their operations and supposed partnerships or advisors. As such, I would not recommend on putting your investment in such a project.

阅读更多
expert-coin.com
News, reviews

Strengths: signed partnerships; very strong team and world-renowned advisors. Thorough market research and clear vision of the market, business model is presented in detailed way.

Weaknesses: no financial plan/projection, no competitor analysis, no marketing plan. The product is technically advanced, this may require additional funds.

阅读更多
查看全部(%count%)
  • 由于信息更新可能存在时间差异,因此应通过其官方网站或其他沟通渠道验证有关每个ICO项目的准确信息。
  • 这些信息不是投资ICO资金的建议或建议。请自行彻底调查相关信息并决定ICO的参与情况。
  • 如果您认为有任何问题需要纠正,或者您想提交自己的ICO项目,请给我们发送电子邮件。
请阅读免责声明和风险警告。 显示免责声明和风险警告。